摘要
Abstract
Objective To compare the effect of rosuvastatin and atorvastatin for treating patients with premature coronary heart disease and acute myocardial infarction(PCHDAMI). Methods Totally 182 patients with PCHDAMI were divided into the observation group and the control group according to the single and double order of admission number,91 cases in each group. The observation group was treated with rosuvastatin,while the control group was treated with atorvastatin. Results After treatment,the levels of blood lipids,LVEF, FMD and hs-CRP in the two groups were significantly improved,and the observation group was improved more obviously(P < 0. 05). The incidence rate of cardiovascular events in the two groups was relatively low,and there was no significant difference between the two groups(P > 0. 05). Conclusion Compare with atorvastatin,revasvastatin is more effective in the treatment of PCHDAMI,which can be selected firstly in the clinical.关键词
瑞舒伐他汀/阿托伐他汀/早发冠状动脉粥样硬化性心脏病/急性心肌梗死/临床疗效Key words
rosuvastatin/atorvastatin/premature coronary heart disease/acute myocardial infarction/clinical effect分类
医药卫生
